MANILA – The Food and Drug Administration (FDA) will revoke the emergency use authorization (EUA) of a coronavirus disease 2019 (COVID-19) vaccine in case the patients develop adverse reactions.
FDA Director General Eric Domingo on Tuesday said adverse effects for any vaccine may result in either the revision of its condition for use or the revocation of its EUA.
This, as Pfizer investigates the reported deaths of elderly people who had received COVID-19 shots in Norway.
Currently, Pfizer is the only COVID-19 vaccine with an EUA in the Philippines.
The FDA official added that an advisory on the elderly may be added if it is proven that the vaccine is linked to the said deaths./PN
